Atypical antipsychotics

Editorial

S Kapur et al. BMJ. 2000.

. 2000 Dec 2;321(7273):1360-1.

doi: 10.1136/bmj.321.7273.1360.

No abstract available

Comment in

Atypical antipsychotics in the treatment of schizophrenia. Paper underrates patients' experience of extrapyramidal symptoms.
Kerwin R. Kerwin R. BMJ. 2001 Apr 14;322(7291):926-7; author reply 927-8. BMJ. 2001. PMID: 11302914 No abstract available.
Atypical antipsychotics in the treatment of schizophrenia. Paper corrupts concept of evidence based medicine.
Adams C, Duggan L. Adams C, et al. BMJ. 2001 Apr 14;322(7291):927-8. BMJ. 2001. PMID: 11302916 No abstract available.
Atypical antipsychotics in the treatment of schizophrenia. Users' views are important.
Anderson I. Anderson I. BMJ. 2001 Apr 14;322(7291):926; author reply 927-8. BMJ. 2001. PMID: 11302919 No abstract available.
Atypical antipsychotics in the treatment of schizophrenia. Cost is a crucial issue.
Duggins R, Rhinds D, Hall W. Duggins R, et al. BMJ. 2001 Apr 14;322(7291):926; author reply 927-8. BMJ. 2001. PMID: 11302921 No abstract available.

Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis.
Geddes J, Freemantle N, Harrison P, Bebbington P. Geddes J, et al. BMJ. 2000 Dec 2;321(7273):1371-6. doi: 10.1136/bmj.321.7273.1371. BMJ. 2000. PMID: 11099280 Free PMC article. Review.

1. Geddes J, Freemantle N, Harrison P, Bebbington P.for the National Schizophrenia Guideline Development Group. Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis BMJ 20003211371–1376. - PMC - PubMed
1. Leucht S, Pitschel-Walz G, Abraham D, Kissling W. Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials. Schizophr Res. 1999;35:51–68. - PubMed
1. Casey DE. Motor and mental aspects of extrapyramidal syndromes. Int Clin Psychopharmacol. 1995;10(suppl 3):105–114. - PubMed
1. Meltzer HY. The role of serotonin in schizophrenia and the place of serotonin-dopamine antagonist antipsychotics. J Clin Psychopharmacol. 1995;15(suppl 1, Feb):2S–23. - PubMed
1. Kapur S, Seeman P. Fast dissociation from the dopamine D2 receptors explains atypical antipsychotic action—a new hypothesis. Am J Psychiatry (in press).